Variables | Sinus tract (n = 52) | Non-sinus tract (n = 55) | P-Value |
---|---|---|---|
Age, yrs. (mean ± SD) | 59.46 ± 16.93 | 63.48 ± 11.64 | 0.085a |
Male, n (%) | 26 (50.0%) | 19 (34.5%) | 0.106b |
BMI, kg/m2 (mean ± SD) | 26.29 ± 5.63 | 26.82 ± 4.17 | 0.581a |
Median CCI, (IQR) | 3 (2, 4) | 3 (2, 4) | 0.317c |
Joint (Hip), n (%) | 17 (32.7%) | 12 (21.8%) | 0.206b |
Revision, n (%) | 12 (23.1) | 8(14.5) | 0.258b |
PJI type, n (%) | Â | Â | 0.182b |
Early PJI | 11 (21.2%) | 14 (25.5%) | Â |
Acute hematogenous PJI | 16 (30.8%) | 24 (43.6%) | |
Chronic PJI | 25 (48.1%) | 17 (30.9%) | |
Culture positive, n (%) | 36 (69.2%) | 36 (65.5%) | 0.677b |
Organism | Â | Â | 0.265d |
 Staphylococcus (MR) | 12 (21.3%) | 10 (18.2%) |  |
 Staphylococcus (MS) | 3 (5.8%) | 5 (9.1%) | |
 Gram-negative | 6 (11.5%) | 5 (9.1%) | |
 Other pathogens | 6 (11.5%) | 13 (23.6%) | |
 Polymicrobial | 9 (17.3%) | 3 (5.5%) | |
 Culture negative | 16 (30.8%) | 19 (34.5%) | |
Modular exchange, n (%) | 34 (65.4%) | 43 (78.2%) | 0.141b |
Topic antibiotics, n (%) | 9 (17.3%) | 12 (21.8%) | 0.557b |
Median follow-up, yrs. (IQR) | 3.18 (1.80, 7.68) | 5.38 (2.42, 7.98) | 0.182c |